I am so glad I looked into other options. It has paid off more than I could hope for.
Mount Sinai, NY (PRWEB) July 29, 2010
Founded in 2005 by Peter K. Sidorenko and Walter Kravchenko, Stem Cells for Hope(SCFH) has been working to break new ground in the field of stem cell transplantation treatment. SCFH is a leader in providing stem cell transplantation treatments for patients suffering from serious neurodegenerative conditions, physical injuries and other debilitating disorders previously deemed untreatable by traditional medicine. The Company has a distinguished and diverse Medical and Scientific Advisory Board which is comprised of Surgeons, MD's, Ph.D.'s and scientists who are responsible for evaluating patients and developing stem cell treatment protocols on a case-by-case basis.
“While I sit here writing about my thoughts, I am deeply grateful for this opportunity no matter how anxious and nervous I am. Tomorrow is not merely just a new day but hopefully the start of a new life and future for me without the daily plague of MS extremes. Goodnight old life and hopefully goodbye to MS.” So began Angela’s journal upon her arrival at the clinic. She presented with severe fatigue, cognitive issues, lack of coordination in her limbs, partial blindness and constant pain. Unable to work, Angela put her last hope into adult stem cell transplantation therapy. “I have spent six months building my faith that this procedure will be the answer in repairing the damage MS has done to me physically. I really don’t want to be disappointed. If it doesn’t work, life will be more living with an illness that is nothing more than a series of mysteries. Multiple Sclerosis appears to be the Polio of the modern era.”
Stem cell transplantation therapy is not FDA approved in the U.S., except in the cases of leukemia and bone marrow cancer in children and some adults. This stem cell transplantation procedure has been performed here for the last 40 years. While the U.S. still uses embryonic stem cells for research and testing purposes on animals, "it will still be 12 to 15 years until any kind of stem cells will be authorized here for actual treatments. That's a long time to wait with nothing in sight for help [for patients]," stated COO Peter K. Sidorenko.
Although based in the U.S., the Company offers services to patients at select medical facilities outside of the country due to the current FDA restrictions. According to Mr. Sidorenko, “The clinics and hospitals that we have in our network have 15 to 18 years of experience in treating human patients with various types of stem cells. Each location has a slightly different treatment protocol depending on the patient’s medical condition.”
“Over the course of this week I am completely in awe of the improvements I am already seeing in myself physically,” writes Angela following her treatment at the clinic. “How exciting my future is truly going to be! It is unbelievable and amazing all at the same time. Miracles still happen.”
Since receiving her treatment, Angela has seen a dramatic improvement in her quality of life. Her limp has disappeared, her pain has subsided, her vision has returned, she has less fatigue and is walking two miles daily. “I have no words with which to explain my feelings or thoughts; what I have written seems lacking on so many levels but it’s the best I can do. I wish I could stand before everyone with this disease and say please choose this because in so doing you’re choosing to take back your life. This is your life, no one else’s but yours, so own it and take it back. No one has to live with MS and sit on the sidelines watching it destroy you, it doesn’t have to be that way,” Angela writes. “I am so glad I looked into other options. It has paid off more than I could hope for.” Angela’s treatment protocol will include a litany of dietary and supplement requirements to help purify her body, as well as a program of exercise and physical therapy, but she is on her way to a new life.
Other medical conditions that have been treated with Stem Cell Therapy include Parkinson's, stroke, macular degeneration, glaucoma, liver cirrhosis and optic nerve damage. Additional conditions are evaluated by the SCFH Medical Advisory Board on a case-by-case basis.
Angela’s journal can be viewed in its entirety by clicking on the following link to: Angela’s Journal.
For additional information regarding Stem Cells for Hope and their stem cell treatment programs, please visit the website at http://www.stemcellsforhope.com or contact us directly.
Peter K. Sidorenko, COO
Stem Cells for Hope
Walter Kravchenko, CEO
Stem Cells for Hope